TheFly.com
Start Free Trial
Open Search
keyboard_arrow_down
Type symbol to search
This symbol is non-existent:
List is empty.
Search
KA
Kineta
$
()
KA
Kineta presents data from Phase 1/2 VISTA-101 clinical trial at AACR
KA
4/8/2024 - 16:08pm
Kineta clears additional cohorts in Phase 1/2 VISTA-101 trial
KA
,
MRK
3/12/2024 - 08:27am
Kineta to reduce workforce by 64% in corporate restructuring
KA
2/29/2024 - 08:35am
Kineta to present new preclinical data on KVA12123
KA
2/22/2024 - 08:32am
Kineta provides update on ongoing Phase 1/2 VISTA-101 trial of KVA12123
KA
1/17/2024 - 08:35am
Kineta publishes preclinical data on KVA12123
KA
12/13/2023 - 08:32am
Kineta announces new data from VISTA-101 trial of KVA12123
KA
11/6/2023 - 08:44am
Kineta files to sell 890K shares of common stock for holders
KA
11/3/2023 - 16:28pm
Kineta announces first patient dosed in Phase 1/2 VISTA-101 trial of KVA12123
KA
,
MRK
10/17/2023 - 08:32am
Kineta presents new preclinical data on anti-CD27 agonist
KA
10/4/2023 - 08:35am
Kineta announces $3M registered direct offering priced at $3.37 per share
KA
10/4/2023 - 08:04am
Kineta announces KVA12123 data from Phase 1/2 VISTA-101 trial
KA
10/3/2023 - 08:38am
Kineta enters research agreement with Fred Hutchinson Cancer Center
KA
9/18/2023 - 09:34am
Kineta reports Q2 EPS 4c vs. ($1.23) last year
KA
8/11/2023 - 16:03pm
Kineta to Receive $5M milestone payment from Merck
KA
,
MRK
6/29/2023 - 06:32am
dynamic_feed
Breaking News
search
Search
menu
Menu